NRXS today
$5.42-$0.33 (-5.74%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $5.31
Key levels
Resistance$6.74
Resistance$5.55
Support$4.13
Support$2.50
Latest news & SEC filings
EarningsNeuraxis posts wider quarterly loss and lower revenue than expected
All NRXS news →About Neuraxis
Neuraxis is a medical technology company that develops neuromodulation therapies for gastrointestinal disorders involving gut-brain interaction. Its main product, IB-Stim, is a non-implanted nerve stimulation device cleared for patients aged 8 and older with functional abdominal pain linked to irritable bowel syndrome and functional dyspepsia. The company also offers RED, a device for evaluating rectal neuromuscular function in adults. Neuraxis focuses on pediatric and adult patients, with clinical trials underway for additional conditions, and sells primarily to children's hospitals and gastroenterology providers in the United States.
Based on the company's 10-K filed Mar 19, 2026.
NYSE · Healthcare
Neuraxis, INC (NRXS)
What Is the Price Target for NRXS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NRXS a Buy or Sell Right Now?
Thesis
- •Revenue growing 32.9% YoY with ACCELERATING trend — accelerating momentum.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NRXS.
Start Free Trial →Is NRXS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$1.37
40
Moat Score
NARROW
4/9
Piotroski Score
-6.0
Altman Z-Score
What Is Smart Money Doing with NRXS?
Insider Signal
BUYING
6 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Carrico Brian Allen | director officer | Buy | 268 | $1K | Oct 8, 2026 |
| Carrico Thomas Joeseph | officer | Buy | 328 | $2K | Oct 8, 2026 |
| Henrichs Timothy Robert | officer | Buy | 1,937 | $9K | Oct 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NRXS Growth Story
Revenue YoY
32.9%
3yr Revenue CAGR
10.0%
EPS Growth YoY
22.13%
FCF Growth YoY
-5.5%
Revenue Trend
ACCELERATING
Dark Pool Trades for NRXS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NRXS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:16:45 | $5.67 | 2,500 | $$14K | BUY |
| 15:02:11 | $5.64 | 1,707 | $$10K | SELL |
| 14:51:33 | $5.71 | 1,500 | $$9K | SELL |
| 14:47:44 | $5.74 | 3,020 | $$17K | BUY |
| 14:44:40 | $5.70 | 1,731 | $$10K | SELL |
5 dark pool trades shown · $$60K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Neuraxis, INC (NRXS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NRXS — frequently asked questions
What is NRXS stock price today?
Neuraxis, INC (NRXS) is at $5.42, down 5.74% (-$0.33) at the Nov 13, 2026 close.
Why is NRXS stock moving today?
Latest NRXS news — Nov 9, 2026: Neuraxis posts wider quarterly loss and lower revenue than expected
Why did NRXS stock move on Oct 15, 2026?
NeurAxis (NRXS) shares surged 12.66% today, closing at $7.74 after opening at $6.87 and trading as high as $7.80 on volume of 745,453. The rally followed the company's announcement that new insurance coverage for its IB-Stim PENFS therapy now serves over 26 million medical plan members, significantly expanding patient access.
What do analysts rate NRXS?
Analyst ratings for NRXS: 2 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did NRXS beat earnings?
NRXS last reported on Aug 11, 2026: EPS -$0.19 vs -$0.32 expected — a beat of 40.6%.
Does NRXS pay a dividend?
NRXS does not currently pay a dividend.
What are NRXS support and resistance levels?
Support: $4.13, $2.50. Resistance: $5.55, $6.74, $7.74.
What are insiders doing with NRXS?
Insider activity: BUYING, 6 buys and 0 sells in the last 90 days.
What is the latest news on NRXS?
Nov 9, 2026: Neuraxis posts wider quarterly loss and lower revenue than expected